KTC1101
KTC1101 is an orally active pan-PI3K inhibitor. KTC1101 can inhibit the PI3K signaling pathway, reduce downstream AKT and mTOR phosphorylation, and reduces the expression of Ki67. The anti-tumor effect of KTC1101 has a dual mechanism of action: directly inhibiting tumor cell growth and dynamically enhancing immune response[1].
Product Specifications
CAS Number
2764833-47-6
UNSPSC
12352005
Target
Akt; mTOR; PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ktc1101.html
Purity
98.09
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
FC(F)C1=NC2=C(OC)C=C(N)C=C2N1C3=NC(N4CCOCCC4)=NC(N5CCOCC5)=N3
Molecular Formula
C21H26F2N8O3
Molecular Weight
476.48
References & Citations
[1]Peng X, et al. A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation. Mol Cancer. 2024 Mar 14;23 (1) :54.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3K; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15198864 1 Vial
Lentiviral mouse Heyl shRNA (UAS) - Lentiviral mouse Heyl shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
orb1341277 100 µg
Estrogen Receptor 1 (ESR1) Human Over-expression Lysate
Sign In for Pricing
View Details 43199154 3x 1.0 µg DNA
SCPEP1 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
Sign In for Pricing
View Details